Vanda Pharmaceuticals Inc (VNDA)
Cost of Revenue
$3.56M
Quarterly · Period ending: · USD
VNDA Cost of Revenue
Latest reported$3.56Mperiod ending
Latest reported$3.56Mperiod ending
VNDA Quarterly Cost of Revenue ($0.00 → $3.56M)
Quarterly cost of revenue
High-resolution chart · PNG
VNDA cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 3,560,000 | |
| 5,146,000 | |
| 3,833,000 | |
| 2,954,000 | |
| 4,487,000 | |
| 3,521,000 | |
| 2,590,000 | |
| 2,551,000 | |
| 4,485,000 | |
| 5,458,000 | |
| 3,460,000 | |
| 3,063,000 | |
| 3,499,000 | |
| 4,774,000 | |
| 6,238,000 | |
| 6,320,000 | |
| 6,059,000 | |
| 5,665,000 | |
| 6,236,000 | |
| 6,797,000 | |
| 6,566,000 | |
| 6,030,000 | |
| 6,412,000 | |
| 5,898,000 | |
| 5,847,000 | |
| 5,207,000 | |
| 6,225,000 | |
| 6,782,000 | |
| 6,368,000 | |
| 5,113,000 | |
| 5,667,000 | |
| 5,068,000 | |
| 5,213,000 | |
| 4,560,000 | |
| 4,791,000 | |
| 4,525,000 | |
| 4,529,000 | |
| 4,003,000 | |
| 5,272,000 | |
| 6,990,000 | |
| 6,494,000 | |
| 5,956,000 | |
| 6,171,000 | |
| 6,510,000 | |
| 5,766,000 | |
| 5,015,000 | |
| 682,000 | |
| 703,000 | |
| 198,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 129,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,117,835 | |
| 376,792 | |
| 1,888,124 | |
| 1,743,919 | |
| 2,291,482 | |
| 376,792 | |
| 229,352 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |